CBD Life Sciences Inc (PK) (CBDL) Quote

Good Morning $CBDL

What are we thinking about this equity? buy, sell, hold?

Another 15 million in dilution. They are late to the market for CBD. It been around a long time. They could never sell enough to make up for the billions in dilution after he each r/s. It never ends. As we see now.

LOI with the New York dispensary. More partnerships and adding new products to our product line! Stay tuned!
$CBDL

We will have a big update next week on our LOI with the New York dispensary. More partnerships and adding new products to our product line! Stay tuned!
$CBDL

Wrong. After all these r/s no one is green but the management selling dilution shares.

Nonsense. The only thing that will be huge. The o/s shares. Billions.

More of the same after the 3rd r/s. It is crazy how people still but these shares. They depend on fools to dump so many. Every day buys filled by dilution.

The CBD Horse Paste is going to be HUGE $CBDL



https://www.accesswire.com/927053/cbd-life-sciences-inc-cbdl-launches-first-of-its-kind-cbd-horse-paste-a-veterinarian-designed-solution-for-equine-wellness

$CBDL is GREEN!

Will they continue expanding into THC if it is made Federally legal ?

CBD Life Sciences Inc. (CBDL) is expanding onto Alibaba’s marketplace, accessing 1.28 billion consumers and $3 trillion in sales potential. With 1405% revenue growth since February 2024, CBDL is poised for massive global expansion and market success.

I see they did a R/S back in April, hopefully they won't do another??

Good Morning $CBDL

Good morning (CBDL-Land & Team).......🤑😎.........Go CBDL & Team

$CBDL Nothing at all changed they put news out to move shares. It’s all about dumping Regulation A shares.

The third time after a r/s. Yet pr's etc trying to tell us what changed. Nothing has.

$CBDL Yeah this will keep dropping. Tom and Lisa Nelson are dumping Regulation A shares as quick as they can clear them.

Exactly what I have been saying. All the buys are filled by dilution. No one is up on this stock.

$CBDL The Regulation A shares are coming fast and this will be no bid sooner than I thought.

I do not see any revenue dollars in these pr;s. Still tiny huh. Keep posting management needs to sell billions of shares to new suckers. Shame on you. Almost back to presplit level of .0001. For a third time.

CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024

CBD Life Sciences Inc. (CBDL) is expanding onto Alibaba’s marketplace, accessing 1.28 billion consumers and $3 trillion in sales potential. With 1405% revenue growth since February 2024, CBDL is poised for massive global expansion and market success.

Did they pr the dollars revenue grew? No. Because it is still tiny. Billions and billions of share issued. Trillions on a presplit basis. There is so many CBD products. Nothoi9ng will justify the dilution. It has destroyed share value multiple times. Anyone buying is blind.

The only thing here that is growing is o/s again as price drops.

I bought more. CBDL Unstoppable Growth

-- By tapping into Alibaba's extensive network of buyers, CBD Life Sciences is positioning itself as a leading supplier of CBD products to retailers around the globe. This expansion is expected to amplify both domestic and international sales, contributing to the already 1405.46% revenue increase the company has experienced since February 2024.

-- Unstoppable Growth and Shareholder Confidence. Since early 2024, CBD Life Sciences has maintained an impressive upward trajectory, breaking records quarter after quarter. Shareholders have witnessed the company's evolution from a pioneering CBD startup to an industry leader with a diverse product line that caters to a growing market of health-conscious consumers. This expansion into Alibaba ensures that CBDL will not only maintain but accelerate this momentum.

Long term growth. Expect success for CBDL
-----------------
"CBD Life Sciences Inc. remains committed to providing best-in-class CBD products, with a portfolio ranging from water-soluble nano CBD formulations to CBD pain relief solutions that continue to set industry standards. The company is also focused on future innovations, with new product launches expected in the upcoming quarters, all designed to deliver unrivaled quality and efficacy.

By leveraging Alibaba's vast wholesale distribution channels, CBD Life Sciences is laying the groundwork for long-term growth and sustainability. Shareholders can expect sustained success, as the company continues to execute on its aggressive global expansion strategy. Every step forward is an opportunity to deliver value and drive substantial returns for those who have invested in the company's vision"

"CBD Life Sciences Inc. (OTC: CBDL) is a leader in the CBD sector, specializing in innovative, high-quality products that utilize cutting-edge nanotechnology for superior bioavailability and maximum health benefits. With a broad portfolio of products, from pain creams to consumables, CBDL is committed to enhancing the lives of its consumers. The company is on a fast-paced trajectory to expand its global presence through retail and wholesale channels, both online and in brick-and-mortar stores"

Longs are so far down after multiple r/s. Who do you think is filling buys? The same as before dilution. The only thing this managements get rich doing is selling shares. That has not change no matter how many Pr's. Keep buying. When at .00001 again your loss. Many said same thing before last 2 r/s. How did that work out? They will never stop the dilution of billions again. 100's of millions in last few week.

"Our entrance into Alibaba is more than just an expansion-it's a game-changer," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "Alibaba's platform opens up access to markets we've only just begun to explore, and this leap forward will not only drive our revenue to new heights but will strengthen our relationship with valued shareholders, who are the backbone of our success."

Wow! This was a Great update for Longs moving forward......🤑😎.....Wow! I will continue to add on Deeps. Wow! Bring it on......🤑😎.......Good morning(CBDL-Land & Team)......Go (CBDL & Team)

SCOTTSDALE, AZ / ACCESSWIRE / October 10, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a trailblazer in the CBD industry, proudly announces a bold new step in its expansion strategy by targeting Alibaba, the world's largest retail and e-commerce platform. With an eye on global dominance, CBDL is set to offer its top-selling CBD products to Alibaba's vast wholesale marketplace, unlocking access to over 1.28 billion annual active consumers and an astounding $3 trillion in gross merchandise volume (GMV). This move marks a significant milestone in CBD Life Sciences' rapid ascent and positions the company for exponential revenue growth and global market penetration.


"Our entrance into Alibaba is more than just an expansion-it's a game-changer," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "Alibaba's platform opens up access to markets we've only just begun to explore, and this leap forward will not only drive our revenue to new heights but will strengthen our relationship with valued shareholders, who are the backbone of our success."

Massive Opportunity: Alibaba's Wholesale Powerhouse

Alibaba is the world's top e-commerce platform, facilitating over $172 billion in cross-border commerce annually. For CBD Life Sciences, this presents a massive opportunity to capitalize on the growing demand for high-quality CBD products in regions where CBD is rapidly gaining popularity. CBDL's flagship products-ranging from nano CBD coffee creamers and pain relief creams-will now be available to wholesalers across Asia, Europe, and beyond.

By tapping into Alibaba's extensive network of buyers, CBD Life Sciences is positioning itself as a leading supplier of CBD products to retailers around the globe. This expansion is expected to amplify both domestic and international sales, contributing to the already 1405.46% revenue increase the company has experienced since February 2024.

Unstoppable Growth and Shareholder Confidence

Since early 2024, CBD Life Sciences has maintained an impressive upward trajectory, breaking records quarter after quarter. Shareholders have witnessed the company's evolution from a pioneering CBD startup to an industry leader with a diverse product line that caters to a growing market of health-conscious consumers. This expansion into Alibaba ensures that CBDL will not only maintain but accelerate this momentum.

As the global CBD market continues to surge-expected to exceed $47 billion by 2028-CBD Life Sciences is at the forefront, making decisive moves to capitalize on this trend. The entry into Alibaba represents a significant milestone, one that promises to multiply revenues and shareholder value in the coming quarters.

"With our entrance into Alibaba, we're taking the brand global at a scale we've never seen before. Our loyal shareholders are at the heart of this growth, and their support allows us to keep pushing boundaries, explore new opportunities, and bring cutting-edge products to consumers worldwide," added Nelson. "Together, we will conquer new markets and achieve new heights."

Looking Ahead: Unwavering Commitment to Innovation and Expansion

CBD Life Sciences Inc. remains committed to providing best-in-class CBD products, with a portfolio ranging from water-soluble nano CBD formulations to CBD pain relief solutions that continue to set industry standards. The company is also focused on future innovations, with new product launches expected in the upcoming quarters, all designed to deliver unrivaled quality and efficacy.

By leveraging Alibaba's vast wholesale distribution channels, CBD Life Sciences is laying the groundwork for long-term growth and sustainability. Shareholders can expect sustained success, as the company continues to execute on its aggressive global expansion strategy. Every step forward is an opportunity to deliver value and drive substantial returns for those who have invested in the company's vision.

About CBD Life Sciences Inc.

CBD Life Sciences Inc. (OTC: CBDL) is a leader in the CBD sector, specializing in innovative, high-quality products that utilize cutting-edge nanotechnology for superior bioavailability and maximum health benefits. With a broad portfolio of products, from pain creams to consumables, CBDL is committed to enhancing the lives of its consumers. The company is on a fast-paced trajectory to expand its global presence through retail and wholesale channels, both online and in brick-and-mortar stores.

Follow our social media for the latest updates!

X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com

$CBDL Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products https://www.accesswire.com/929597/cbd-life-sciences-inc-cbdl-targets-alibaba-as-the-next-retail-giant-for-wholesale-expansion-of-top-selling-cbd-products

$CBDL Good news no reverse split. They have a big history of reverse splitting stocks. The regulation A will dilute and after this hits .0001 again they will reverse split. It’s a printing machine to sell stock.

$CBDL This thing is going nowhere and Tom and Lisa Nelson are handing out shares like holloween candy with that Regulation A. Many shares coming

Big Day Coming $CBDL

Another 12 million in dilution. LOL. So do many others and have for a lot longer. Did the management spend all the dilution money? They are putting out a lot of pr's to sell more billions of shares. Anyone buying the shares. Like before the last 2 r/s. Will lose it all.

Innovative Product Line: CBDL offers a range of popular products, including CBD Pain Relief Cream Roll-On and CBD Pet Treats, catering to a diverse consumer base and tapping into the wellness trend?

They reached expected dilution again and lower share prices again. The buys are filled by dilution as no one has a gain after 2 r/s.

CBD Life Sciences, Inc. ($CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024

OTCMKTS: CBDL Market Expansion: With the global CBD market projected to exceed $20 billion by 2025, CBDL is well-positioned to capture a significant share of this growing market

The only thing growing is the o/s share . What are the dollars of revenue not a %.

Remarkable growth

“This remarkable growth was driven by our aggressive expansion into new retail markets. By entering Amazon and Walmart Marketplace, two of the largest retail platforms globally, we have unlocked access to over $950 billion in combined annual consumer spending. This strategic move has resulted in a 300% growth in online sales since launch, and we're just getting started”

Remarkable growth

“This remarkable growth was driven by our aggressive expansion into new retail markets. By entering Amazon and Walmart Marketplace, two of the largest retail platforms globally, we have unlocked access to over $950 billion in combined annual consumer spending. This strategic move has resulted in a 300% growth in online sales since launch, and we're just getting started”

Good news is: No R/S, good growth, good planning
“an extraordinary opportunity to capitalize on one of the fastest-growing companies in the CBD space. The company has no intentions of doing reverse split. Our relentless focus on innovation, strategic market entry, and partnerships with leading retailers positions us to not only meet but exceed your expectations in the near future”

Lesson. Sucker purchase. Reg A purchaser makes 20 percent and you hope for the best.

Reg A is priced at 5 cents which is why you have all the supply at 6 cents

We will have another big update for you all tomorrow! Stay tuned.
$CBDL

Good Morning $CBDL

Good morning (CBDL -Land & Team).....🤑😎......Go (CBDL & Team)

Junk!!

How about using what the revenues dollars were and are now. Help them sell billions of shares is helping these crooks.